AbCellera Biologics (ABCL) Stock Chart & Stock Price History $3.34 +0.32 (+10.43%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AbCellera Biologics Stock Price Performance The AbCellera Biologics (ABCL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 2.77%, with a year-to-date return of 13.82%. In the past month, the stock has increased 64.29%, reflecting recent market activity. As of the latest close, AbCellera Biologics traded at $3.02 with a market cap of $901.24 million and volume of 17.76 million shares. Receive ABCL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+36.68%1 Month Performance+64.29%3 Month Performance+49.55%Year-To-Date Performance+13.82%1 Year Performance-2.77% ABCL Stock Chart for Wednesday, June, 11, 2025 ABCL Chart by TradingView AbCellera Biologics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$2.51$3.02+20.32%$3.04$2.5317.76 million shs$901.24 million06/09/2025$2.44$2.51+2.87%$2.53$2.454.55 million shs$749.04 million06/06/2025$2.37$2.44+2.95%$2.49$2.383.80 million shs$728.16 million06/05/2025$2.42$2.37-2.07%$2.44$2.334.06 million shs$707.27 million06/04/2025$2.31$2.42+4.76%$2.44$2.274.05 million shs$722.19 million06/03/2025$2.14$2.31+7.94%$2.34$2.094.97 million shs$689.36 million06/02/2025$2.02$2.14+5.94%$2.16$2.024.02 million shs$638.63 million05/30/2025$2.04$2.02-0.98%$2.04$1.982.10 million shs$602.82 million05/29/2025$2.04$2.04$2.08$2.001.63 million shs$608.79 million05/28/2025$1.98$2.04+3.03%$2.07$1.972.49 million shs$608.79 million Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$1.97$1.98+0.51%$2.06$1.972.12 million shs$590.88 million05/26/2025$1.97$1.97$1.99$1.941.67 million shs$587.90 million05/23/2025$2.00$1.97-1.50%$1.99$1.941.67 million shs$587.90 million05/22/2025$1.99$2.00+0.50%$2.02$1.942.43 million shs$596.85 million05/21/2025$2.09$1.99-4.78%$2.09$1.972.34 million shs$593.86 million05/20/2025$2.02$2.09+3.47%$2.14$1.993.93 million shs$623.71 million05/19/2025$2.03$2.02-0.49%$2.04$1.982.30 million shs$602.82 million05/16/2025$2.02$2.03+0.50%$2.06$2.003.39 million shs$605.80 million05/15/2025$2.05$2.02-1.46%$2.06$1.963.07 million shs$602.82 million05/14/2025$2.10$2.05-2.38%$2.21$2.016.61 million shs$611.77 million05/13/2025$2.06$2.10+1.94%$2.12$1.9517.01 million shs$626.69 million05/12/2025$2.03$2.06+1.48%$2.15$2.044.39 million shs$614.75 million Related Companies Lyell Immunopharma Stock Chart Apellis Pharmaceuticals Stock Chart Organon & Co. Stock Chart HUTCHMED Stock Chart ImmunityBio Stock Chart Amneal Pharmaceuticals Stock Chart Xenon Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart Arrowhead Pharmaceuticals Stock Chart Ascentage Pharma Group International Stock Chart Receive ABCL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABCL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABCL Stock Free ABCL Stock Alerts